Safety With Echocardiographic Contrast Agents

Circulation. Cardiovascular imaging - United States
doi 10.1161/circimaging.116.005459
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Myocardial Contrast Agents – Safety Considerations and Clinical Efficacy in Stress Echocardiography

ARS Medica Tomitana
BiochemistryMedicineGeneticsMolecular Biology
2016English

Safety and Risk—Benefit Profile of Microbubble Contrast Agents in Echocardiography

Asia Pacific Cardiology
2008English

Spontaneous Echocardiographic Contrast in Constrictive Pericarditis

CASE
2018English

Detecting Enzyme Activities With Exogenous MRI Contrast Agents

Chemistry - A European Journal
Organic ChemistryCatalysisChemistry
2014English

Evaluation of Microbubble Contrast Agents for Dynamic Imaging With X-Ray Phase Contrast

Scientific Reports
Multidisciplinary
2015English

Polycatechol Nanoparticle MRI Contrast Agents

Small
Materials ScienceNanoscienceEngineeringBiomaterialsMedicineBiotechnologyNanotechnologyChemistry
2015English

Safety of Gadolinium-Based Contrast Agents in Patients With Stage 4 and 5 Chronic Kidney Disease: A Radiologist’s Perspective

Kidney360
2020English

Contrast Agents in Dynamic Contrast-Enhanced Magnetic Resonance Imaging

Oncotarget
Oncology
2017English

Association of Left Atrial Spontaneous Echocardiographic Contrast With Inflammatory Markers in Mitral Stenosis Patients

Cardiovascular Journal
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy